Xencor (XNCR)
(Real Time Quote from BATS)
$21.34 USD
+0.49 (2.35%)
Updated Sep 19, 2024 10:32 AM ET
3-Hold of 5 3
F Value F Growth A Momentum F VGM
Brokerage Reports
Xencor, Inc. [XNCR]
Reports for Purchase
Showing records 1 - 20 ( 221 total )
Company: Xencor, Inc.
Industry: Medical - Drugs
Company: Xencor, Inc.
Industry: Medical - Drugs
Company: Xencor, Inc.
Industry: Medical - Drugs
Company: Xencor, Inc.
Industry: Medical - Drugs
Company: Xencor, Inc.
Industry: Medical - Drugs
Company: Xencor, Inc.
Industry: Medical - Drugs
Company: Xencor, Inc.
Industry: Medical - Drugs
Company: Xencor, Inc.
Industry: Medical - Drugs
Company: Xencor, Inc.
Industry: Medical - Drugs
Optimized Entry and Exit Levels for XNCR 112223
Provider: Stock Traders Daily
Analyst: Research Department
Company: Xencor, Inc.
Industry: Medical - Drugs
Company: Xencor, Inc.
Industry: Medical - Drugs
Company: Xencor, Inc.
Industry: Medical - Drugs
Company: Xencor, Inc.
Industry: Medical - Drugs
ESMO 2023 Abstract Roundup For Covered Companies
Provider: Wedbush Securities Inc.
Analyst: NIERENGARTEN D
Company: Xencor, Inc.
Industry: Medical - Drugs
Company: Xencor, Inc.
Industry: Medical - Drugs
Company: Xencor, Inc.
Industry: Medical - Drugs
Company: Xencor, Inc.
Industry: Medical - Drugs
Company: Xencor, Inc.
Industry: Medical - Drugs
Company: Xencor, Inc.
Industry: Medical - Drugs
Company: Xencor, Inc.
Industry: Medical - Drugs
XmAb808 (B7-H3 x CD28) preclinical platform validation on two fronts
Provider: Wedbush Securities Inc.
Analyst: NIERENGARTEN D